PORTHCAWL, Wales -- Rio Takeda overcame a double bogey at the turn with four birdies over her final seven holes Thursday for ...

England's Lottie Woad endured a frustrating start to the AIG Women's Open as Japan's Eri Okayama and Rio Takeda topped the ...

Despite revenue declines, Takeda Pharmaceutical Co Ltd (TKPHF) showcases promising pipeline advancements and strategic debt ...

Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the first quarter of fiscal year 2025 (three months ended ...

Rio Takeda overcame a double bogey at the turn with four birdies over her final seven holes Thursday for a 5-under 67 to ...

Takeda reported a 30% rise in Q1 profit and beat EPS estimates, offsetting Vyvanse losses with growth in oncology, plasma, ...

Rio Takeda and Eri Okayama shared the lead at 5-under par after the first round of the Women's British Open on Thursday as Japanese players dominated the leaderboard at Royal Porthcawl. World No. 12 ...

Wrestling legend Hulk Hogan's cause of death revealed ESPN's College Football Anthem Decision Sparks Strong Reaction Mom Worried If New Rescue Dog Had ‘Bonded’ With Baby, Then She Caught Them ...

Rio Takeda and Eri Okayama of Japan shot matching rounds of 67 to take the lead after one round of the AIG Women's Open on Thursday in Porthcawl, Wales.

Takeda, coming off a high of 2024 growth, is pushing through what it says will be the worst of its Vyvanse-related declines.

Discover why Takeda Pharmaceutical Company Limited remains a solid Buy. Click to explore TAK and its drug pipeline, growth potential, and balanced risk profile.